Item 7.01 Regulation FD Disclosure.
On January 11, 2022, SomaLogic,
Inc. (the “Company”) issued a press release providing a business
update on its estimated year-end revenue results for its fiscal year ending December 31, 2021, which it will discuss during its virtual
presentation at the annual J.P. Morgan Healthcare Conference on January 11, 2022 at 8:15 a.m. Eastern Time. The Company’s press
release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. A live audio webcast of the
presentation along with a copy of the Company presentation materials from the conference will be available through the investor page at
the Company’s website: investors.somalogic.com.
The information in this Item
7.01 of this Current Report on Form 8-K and the exhibit hereto shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it
be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any
general incorporation by reference language in such filing.
The Company’s actual
results may differ materially from the preliminary information provided in the accompanying press release. Factors that could cause these
preliminary estimates to differ include, but are not limited to, discovery of new information that alters expectations about such results
or impacts valuation methodologies underlying such results.
This Current Report on Form
8-K and the accompanying press release contain certain forward-looking statements within the meaning of the federal securities laws, including
statements relating to the expected future performance of the Company. These forward-looking statements, including the Company’s
2021 revenue outlook, are not historical and generally are identified by the words “believe,” “project,” “expect,”
“anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,”
“plan,” “may,” “should,” “will,” “would,” “will be,” “will
continue,” “will likely result,” and similar expressions that relate to the Company’s strategy, expectations,
plans, or intentions. All statements the Company makes relating to its estimated and projected financial results or to its expectations
regarding future trends are forward-looking statements. In addition, the Company, through its senior management team, from time
to time makes forward-looking public statements concerning its expected future operations and performance and other developments.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations
and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements do not guarantee future performance
and involve known and unknown risks, uncertainties and other factors. Many factors could cause actual results and events to differ
materially from the forward-looking statements in this press release, including factors which are beyond the Company’s control.
Investors should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Proxy Statement/Prospectus
filed with the Securities and Exchange Commission (the “SEC”) on August 12, 2021 and the Company’s Current Report on
Form 8-K filed with the SEC on September 8, 2021, as well as subsequent annual and periodic reports filed with the Securities and Exchange
Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ
materially from those contained in the forward-looking statements. All forward-looking information and subsequent written and oral forward-looking
statements attributable to the Company, or to persons acting on its behalf, are expressly qualified in their entirety by the cautionary
statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking
statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as
a result of new information, future events, or otherwise. The Company does not give any assurance that it will achieve its expectations.